Susquehanna Growth Equity (SGE) has appointed David Spitz as a Senior Adviser in the firm’s Portfolio Value Creation team. In this role, Spitz will mentor and support SGE portfolio company leadership teams while helping SGE extend relationships with entrepreneurs in the Carolinas and beyond.   Spitz is the CEO of ChannelAdvisor

Louise Lawlor has been appointed as Group Chief Financial Officer at Centaur Fund Services in Dublin.Read the full story at Hedgeweek…

LBO France has appointed Thibaud Nonotte-Varly as Investor Relations Director, effective 1 September 2020.Nonotte-Varly is joining LBO France from Rothschild & Co, where he was Investor Relations Director for eight years.  LBO partnered with lower and middle market Private Equity specialists Raw Selection on making the appointment and in particular

Lowenstein Sandler is pleased to announce that Rossie E Turman III has joined the firm as Chair of its International Finance practice. Turman will be an integral part of the firm’s Debt Financing group and The Tech Group. He joins Lowenstein’s New York office after 21 years at Skadden, Arps,

Reech Corporations Group, an investment company driving long-term value in real estate, technology and finance, has launched a new growth investor – Odysseus Investments. The business will be headed up by Adam Battersby, formerly Head of Global Principal Investments at BofA Merrill Lynch.   Odysseus Investments will focus primarily on opportunities

Schulte Roth & Zabel (SRZ) has appointed experienced private funds partner Owen Schmidt as a partner in its Investment Management Group. Read the full story at Hedgeweek…

Ara Partners, a private equity firm specialising in industrial decarbonisation investment, has expanded its senior management team through the addition of Tuan Tran as a Managing Director. Tran brings over 20 years of private equity and corporate finance experience across the industrial, environmental services and energy technology sectors, which aligns

MPM Capital, a life-sciences venture capital firm investing in early-stage therapeutics companies, has appointed Matthew Roden PhD, as an Executive Partner. Roden will be responsible for identifying and assessing new technologies and advising portfolio executives on both business and clinical strategies. Roden brings deep and broad biopharmaceutical experience in both operating

Investcorp, a global provider and manager of alternative investment products, has appointed David Moffitt as Co-Head of the company’s US Credit Management business. Moffitt will be based in New York and report to Jeremy Ghose, Global Head of Investcorp Credit Management.   Moffitt brings to Investcorp more than 20 years of